Your browser doesn't support javascript.
loading
Treatment of Super-Refractory Status Epilepticus.
Bayrlee, Ahmad; Ganeshalingam, Nimalya; Kurczewski, Lisa; Brophy, Gretchen M.
Affiliation
  • Bayrlee A; Department of Neurology, Virginia Commonwealth University, P.O. Box 980599, Richmond, VA, 23298, USA, abayrlee@vcu.edu.
Curr Neurol Neurosci Rep ; 15(10): 66, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26299274
Super-refractory status epilepticus (SRSE) is a devastating neurological condition with limited treatment options. We conducted an extensive literature search to identify and summarize the therapeutic options for SRSE. The search mainly resulted in case reports of various pharmacologic and non-pharmacologic treatments. The success rate of each of the following agents, ketamine, inhaled anesthetics, intravenous immunoglobulin G (IVIG), IV steroids, ketogenic diet, hypothermia, electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and vagal nerve stimulation (VNS), are discussed in greater detail. The choice of appropriate treatment options for a given patient is based on clinical presentation. This review focuses on evidence-based, pharmacotherapeutic strategies for patients in SRSE.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Status Epilepticus / Anticonvulsants Limits: Humans Language: En Journal: Curr Neurol Neurosci Rep Journal subject: NEUROLOGIA Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Status Epilepticus / Anticonvulsants Limits: Humans Language: En Journal: Curr Neurol Neurosci Rep Journal subject: NEUROLOGIA Year: 2015 Type: Article